The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors
- PMID: 16476831
- DOI: 10.1634/theoncologist.11-2-96
The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors
Abstract
Significance: There are 2.2 million breast cancer survivors, and approximately 25%-30% of newly diagnosed women each year are <50 years of age. Adjuvant therapy has prolonged survival, but the quality of that survival is influenced by persistent and late effects of therapy. Knowledge of treatment outcomes will assist in the design of interventions to prevent or manage persistent and late effects in survivors.
Purpose: The purpose of this paper is to review the incidence of gonadal toxicity associated with adjuvant chemotherapy, side effects of endocrine therapy, quality of life outcomes, fertility concerns, and options to preserve fertility in young (<35 years) and young midlife (35-50 years) breast cancer survivors.
Results: Alkylating agent-based chemotherapy causes destruction of primordial follicles and impairment of follicular maturation resulting in temporary preservation of menses, reversible amenorrhea, irregular menses (perimenopause), or irreversible amenorrhea (ovarian failure--menopause). Younger women have a lower risk for amenorrhea with chemotherapy because of sufficient follicular stores, although the gonadal toxicity will result in an earlier than expected menopause. Premature menopause is associated with poorer quality of life, decreased sexual functioning, menopausal symptom distress, psychosocial distress related to fertility concerns, infertility, and uncertainty about late effects of premature menopause. Routine discussion about the menopausal experience, risks for infertility, and fertility preservation options is recommended.
Implications for practice: This review identified adverse treatment outcomes for young and young midlife breast cancer survivors that can be minimized or prevented with targeted interventions.
Similar articles
-
Ovarian function and childbearing issues in breast cancer survivors.Gynecol Endocrinol. 2007 Nov;23(11):625-31. doi: 10.1080/09513590701582406. Gynecol Endocrinol. 2007. PMID: 17926162 Review.
-
The menopausal symptom experience in young mid-life women with breast cancer.Cancer Nurs. 2001 Jun;24(3):201-10; quiz 210-1. Cancer Nurs. 2001. PMID: 11409064
-
Fertility and adjuvant treatment in young women with breast cancer.Breast. 2007 Dec;16 Suppl 2:S175-81. doi: 10.1016/j.breast.2007.07.029. Epub 2007 Sep 4. Breast. 2007. PMID: 17804236 Review.
-
The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study.Psychooncology. 2003 Jul-Aug;12(5):500-11. doi: 10.1002/pon.685. Psychooncology. 2003. PMID: 12833562
-
Amenorrhea following chemotherapy for breast cancer: effect on disease-free survival.Oncology (Williston Park). 1994 Dec;8(12):45-52. Oncology (Williston Park). 1994. PMID: 7888312 Review.
Cited by
-
Improving quality of life among latino cancer survivors: Design of a randomized trial of patient navigation.Contemp Clin Trials. 2019 Jan;76:41-48. doi: 10.1016/j.cct.2018.11.002. Epub 2018 Nov 3. Contemp Clin Trials. 2019. PMID: 30399442 Free PMC article.
-
Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study.BMC Cancer. 2019 Jul 4;19(1):659. doi: 10.1186/s12885-019-5882-z. BMC Cancer. 2019. PMID: 31272420 Free PMC article.
-
Sexual functioning in young women in the context of breast cancer treatment.Rep Pract Oncol Radiother. 2013 May 24;18(4):193-200. doi: 10.1016/j.rpor.2013.04.032. Rep Pract Oncol Radiother. 2013. PMID: 24416553 Free PMC article. Review.
-
Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II data.CPT Pharmacometrics Syst Pharmacol. 2024 Dec;13(12):2137-2149. doi: 10.1002/psp4.13226. Epub 2024 Sep 18. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 39295152 Free PMC article.
-
Predicting physical quality of life among a multiethnic sample of breast cancer survivors.Qual Life Res. 2010 Aug;19(6):789-802. doi: 10.1007/s11136-010-9642-4. Epub 2010 Mar 27. Qual Life Res. 2010. PMID: 20340047
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical